NCT06491667View on ClinicalTrials.gov

NLR AND CRP Useful as Cost-Effective Preliminary Prognostic Markers in ST-Elevation Myocardial Infarction

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions
STEMI
Interventions
DIAGNOSTIC_TEST

CBC

Explore the role of Neutrophil-lymphocyte ratio C-reactive protein in predicting the imediate and short-term prognosis in ST-segment elevation myocardial infarction

DIAGNOSTIC_TEST

C-reactive protein

Explore the role of Neutrophil-lymphocyte ratio C-reactive protein in predicting the imediate and short-term prognosis in ST-segment elevation myocardial infarction

Trial Locations (1)

Unknown

RECRUITING

Sohag university hospital, Sohag

All Listed Sponsors
lead

Sohag University

OTHER